Prostate health market is anticipated to grow at a significant CAGR of around 8.8% during the forecast period. The increasing prevalence of benign prostatic hyperplasia is considered as the primary factor attributable to the growth in the prostate health market. Benign prostatic hyperplasia (BPH) is known as a medical condition that affects men adversely through the non-cancerous enlargement of the prostate gland. While BPH seldomly shows symptoms before the age of 40, the risk of shrink in BPH increases with age. As per the World Health Organizations (WHO), the BPH is commonly diagnosed in approximately 50% of men between the ages of 51 and 60 and up to 90% of men older than 80.
The prostate health market has been adversely impacted by the sudden emergence of the COVID-19 infection due to the halt in diagnostic procedures and surgical procedures. Moreover, prostate cancer patients, are more susceptible to COVID-19 infections compared to an individual without cancer, as they are in an immunosuppressive state caused by the malignancy and anticancer treatment. There was a significant decrease in prostate-related diseases diagnosis rates globally, which had shown the negative impact for that short period.
The global prostate health market is segmented based on disease indication and treatment. Based on the disease indication, the market is segmented into prostate cancer, benign prostatic hyperplasia, and prostatitis. Based on the treatment, the market is sub-segmented into chemotherapy, biological therapy, hormone therapy, and others. The other treatment includes medications. Among these, prostate cancer expected to account for the prominent market share in the prostate health market.
To Request a Sample of our Report on Prostate Health Market: https://www.omrglobal.com/request-sample/prostate-health-market
Prostate Health Market Segmentation
By Disease Indication
- Prostate Cancer
- Benign Prostatic hyperplasia
- Prostatitis
By Treatment
- Chemotherapy
- Biological Therapy
- Hormone Therapy
- Others (Medications)
A full Report of Prostate Health Market is Available @ https://www.omrglobal.com/industry-reports/prostate-health-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Abbott Laboratories
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca
- BDR Pharmaceuticals Internationals Pvt. Ltd.
- Dendreon Pharmaceuticals LLC.
- Reddy’s Laboratories Ltd.
- eFFECTOR Therapeutics, Inc.
- Emcure Pharmaceuticals Ltd.
- Endo International plc.
- Essa Pharma Inc.
- Ferring B.V.
- Ipsen Pharma,
- Mediolanum FarmaceuticiSpA
- Merck & Co., Inc.
- Myovant Sciences GmbH.
- Novartis AG
- Pfizer Inc.
- Profound Medical Corp.
- Tolmar Pharmaceuticals, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/prostate-health-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
